These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 9571219

  • 1. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S, Duncan CA, Slaughter DE, Arison BH, Greber T, Olah TV, Vyas KP.
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [Abstract] [Full Text] [Related]

  • 2. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.
    Vickers S, Duncan CA, Kari PH, Homnick CF, Elliott JM, Pitzenberger SM, Hichens M, Vyas KP.
    Drug Metab Dispos; 1993 May; 21(3):467-73. PubMed ID: 8100503
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [Abstract] [Full Text] [Related]

  • 9. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C, Cui D, Potchoiba MJ, Butler T.
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S, Duncan CA, Arison BH, Davies RO, Ferguson R, Zacchei AG.
    Drug Metab Dispos; 1980 Aug; 8(3):163-7. PubMed ID: 6104580
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of labetalol by animals and man.
    Martin LE, Hopkins R, Bland R.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.
    Tocco DJ, deLuna FA, Duncan AE, Walker RW, Arison BH, Vandenheuvel WJ.
    Drug Metab Dispos; 1979 Aug; 7(5):330-4. PubMed ID: 40776
    [Abstract] [Full Text] [Related]

  • 20. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W, Hendrickx J, Lauwers W, Swysen E, Hurkmans R, Knaeps F, Woestenborghs R, Heykants J.
    Drug Metab Dispos; 1984 Aug; 12(6):772-81. PubMed ID: 6150829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.